The November 24, 2020 proposed 2022 Notice of Benefit and Payment Parameters (“2022 NBPP”) set ACA Out-of-Pocket Limitations at $9,100 for self-only coverage and $18,200 for other than self-only coverage. However, the HHS finalized a change in the calculation of the premium adjustment percentage and cost-sharing parameters in its 19 January 2021 final 2022 NBPP and lowered the values for the 2022 plan year limitations on cost-sharing.
The maximum out-of-pocket limits for plan years beginning on or after January 1, 2022 are as follows:
|2021||2022||Change from 2021|
On May 10, 2021, the IRS released Rev. Proc. 2021-25 which sets forth the health savings account (“HSA”) and high deductible health plan (“HDHP”) limits for 2022.
|HSA Contribution Limit||Self-Only: $3,600|
|Catch-Up Contribution Limit (for HSA-eligible participants who turn 55 by year-end||$1,000||$1,000|
|Minimum HDHP Deductible||Self-Only: $1,400|
|HDHP OOP Maximum||Self-Only: $7,000|
Section 214 of the Consolidated Appropriations Act of 2021 (the “CAA”) allows employers to amend their health FSA plans, among other things, so that participants do not have to give up unused amounts for the 2020 and 2021 plan years. On February 18, 2021, the IRS issued Notice 2021-15 which gives employers guidance on what they can amend their § 125 cafeteria plans to include, such as:
– Allowing participants to carry over unused amounts of their health FSAs from the 2020 and 2021 plan years;
– Extending the allowable period for incurring claims in 2020 and 2021;
– Granting a special claims period and carryover rule for dependent care assistance programs; and
– Allowing particular mid-year election changes for the health FSA and dependent care programs for plan years ending in 2021.
Employers should note that the options outlined in Notice 2021-15 are optional and not required. However, any relief options that the employer chooses to adopt, must be documented in a plan amendment, and operate consistently with the changes made beginning with the effective date of the change.
The IRS issued Rev. Proc. 2021-36 on September 7, 2021, which decreases the affordability threshold for ACA employer mandate purposes to 9.61% for plan years beginning in 2022 for employers using a safe harbor to avoid § 4980H(b) Employer Shared Responsibility Provision penalties.
|Jurisdiction||2021 Poverty Guidance||Maximum Self-Only Monthly Contribution (2021)|
|Any Other US State||$12,880||$103.15|
|District of Columbia||$12,880||$103.15|
For more information about ESRP, generally, please visit https://sgp.fas.org/crs/misc/R45455.pdf, and for more information regarding the safe harbor(s) please visit https://www.govinfo.gov/content/pkg/FR-2014-02-12/pdf/2014-03082.pdf.
On January 15, 2021 CMS issued the 2022 Medicare Advantage and Part D Rate Announcement, which includes the Part D Benefit Parameters used to determine whether coverage is creditable for required disclosures. Table V-2, pp. 75-76, show the “Standard Benefit” parameters for 2022 which will be used to determine whether coverage is creditable:
|Standard Benefit||2022 Parameter||Change from 2021|
|Initial Coverage Limit||$4,430||+$300|
|Out-of-Pocket Threshold (See FN1)||$7,050||+$500|
|Total Covered Part D Spending at the Out-of-Pocket Threshold for Non-Applicable Beneficiaries (defined in FN3)||$10,012.50||+$698.75|
|Estimated Total Covered Part D Spending for Applicable Beneficiaries (defined in FN4)||$10,690.20||+$641.81|
|Minimum Cost-Sharing in Catastrophic Coverage Portion of the Benefit (Generic/Preferred Multi-Source Drugs)||$3.95||+$0.25|
|Minimum Cost-Sharing in Catastrophic Coverage Portion of the Benefit (Other)||$9.85||+$0.65|
§ 2713 of the Affordable Care Act provides sources for preventive services that must be covered under the health reform law without cost sharing requirements, which are generally summarized at https://www.healthcare.gov/coverage/preventive-care-benefits/. The specific resources for employers and plan advisors to review include “evidence-based items or services that have in effect a rating of ‘A’ or ‘B’ in the current recommendations of the United States Preventive Services Task Force” (“USPSTF”). Find more specific guidance here. The following items were released in 2021:
|Topic||Description||Grade||Release Date of Current Recommendation|
|Colorectal Cancer: Screening: adults aged 50 to 75 years||The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years. See the "Practice Considerations" section and Table 1 for details about screening strategies.||A||May 2021*|
|Colorectal Cancer: Screening: adults aged 45 to 49 years||The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. See the "Practice Considerations" section and Table 1 for details about screening strategies||B||May 2021*|
|Gestational Diabetes: Screening: asymptomatic pregnant persons at 24 weeks of gestation or after||The USPSTF recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.||B||August 2021*|
|Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions: pregnant persons||The USPSTF recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.||B||May 2021|
|Hypertension in Adults: Screening: adults 18 years or older without known hypertension||The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.||A||April 2021*|
|Lung Cancer: Screening: adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years||The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.||B||March 2021*|
|Screening for Prediabetes and Type 2 Diabetes: asymptomatic adults aged 35 to 70 years who have overweight or obesity||The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.||B||August 2021|
|Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions: pregnant persons||The USPSTF recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.||A||January 2021*|
*Previous recommendation was an “A” or “B.”
The HHS, under the standards set out in revised Section 2713(a)(5) of the Public Health Service Act and Section 9(h)(v)(229) of the 2015 CAA, utilizes the 2002 recommendation on breast cancer screening of the USPSTF. To see the USPSTF 2016 recommendation on breast cancer screening, go to http://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening1.
View FAQ 47 for further clarification on the USPSTF recommendations and implementation of the ACA.
IRS Notice 2020-44 reiterates that the Further Consolidated Appropriations Act, 2020 (Pub. L. 116-94), signed into law on December 20, 2019, has extended the PCORI Fee imposed by Internal Revenue Code sections 4375 and 4376 for 10 years through 2029. As Healthgram’s Q1, 2020 Compliance Update states:
– The Patient-Centered Outcomes Research Institute (PCORI) was established under ACA to conduct research to evaluate the effectiveness of medical treatments, procedures, and strategies that treat, manage, diagnose, or prevent illness or injury.
– The research considers both the effectiveness of the treatment, as well as an individual’s decisions and outlook regarding the treatment.
– The PCORI fee requires self-insured employers and insurers to pay an annual fee to fund the medical research.
2022 FSA Contribution Limits will be announced soon. Once that information is released, we’ll update this section accordingly.
|FSA Contribution Limit||$2,750||To Be Announced|
To speak with a member of our team regarding Healthgram self-funded plans, contact us here.
Click here to download a PDF version of this insight.